Jianliang Shen

Dr. Jianliang Shen

Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou, Zhejiang 325001, China
+1
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 June 2022 in Advanced Materials
Verified
Journal Article
Closed access
YQYuna Qian
Yuna Qian
YZYujing Zheng
Yujing Zheng
JJJuan Jin
Juan Jin
XWXuan Wu
Xuan Wu
KXKejia Xu
Kejia Xu
JSJianliang Shen
Jianliang Shen

22 February 2022 in Advanced Science
Verified
Journal Article
Open access
XQXiaoliang Qi
Xiaoliang Qi
YHYijing Huang
Yijing Huang
SYShengye You
Shengye You
YXYajing Xiang
Yajing Xiang
ECErya Cai
Erya Cai
JSJianliang Shen
Jianliang Shen
Polydopamine (PDA) nanoparticles have emerged as an attractive biomimetic photothermal agent in photothermal antibacterial therapy due to their ease of synthesis, good biodegradability, long‐term safety, and excellent photostability. However, the therapeutic effects of PDA nanoparticles are generally limited by the low photothermal conversion efficiency (PCE). Herein, PDA@Ag nanoparticles are synthesized via growing Ag on the surface of PDA nanoparticles and then encapsulated into a cationic guar gum (CG) hydrogel network. The optimized CG/PDA@Ag platform exhibits a high PCE (38.2%), which is more than two times higher than that of pure PDA (16.6%). More importantly, the formulated CG/PDA@Ag hydrogel with many active groups can capture and kill bacteria through effective interactions between hydrogel and bacteria, thereby benefiting the antibacterial effect. As anticipated, the designed CG/PDA@Ag system combined the advantages of PDA@Ag nanoparticles (high PCE) and hydrogel (preventing aggregation of PDA@Ag nanoparticles and possessing inherent antibacterial ability) is demonstrated to have superior antibacterial efficacy both in vitro and in vivo. This study develops a facile approach to boost the PCE of PDA for photothermal antibacterial therapy, providing a significant step forward in advancing the application of PDA nano‐photothermal agents.

25 October 2023 in Advanced Materials
Verified
Journal Article
Closed access
Xiaoliang QiXiaoliang Qi
Xiaoliang Qi
ECErya Cai
Erya Cai
YXYajing Xiang
Yajing Xiang
CZChaofan Zhang
Chaofan Zhang
XGXinXin Ge
XinXin Ge
JSJianliang Shen
Jianliang Shen

1 January 2022 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
WPWenhao Pan
Wenhao Pan
Xiaoliang QiXiaoliang Qi
Xiaoliang Qi
YXYajing Xiang
Yajing Xiang
SYShengye You
Shengye You
ECErya Cai
Erya Cai
DHDeng Hui
Deng Hui

2 April 2025 in Cell Biomaterials
Verified
Journal Article
Closed access
XQXiaoliang Qi
Xiaoliang Qi
YLYing Li
Ying Li
YXYajing Xiang
Yajing Xiang
YCYuxi Chen
Yuxi Chen
YSYizuo Shi
Yizuo Shi
JSJianliang Shen
Jianliang Shen

10 March 2022 in Advanced Science
Verified
Journal Article
Open access
XHXiaojun He
Xiaojun He
LDLixiong Dai
Lixiong Dai
LYLisong Ye
Lisong Ye
XSXiaoshuai Sun
Xiaoshuai Sun
OEObeng Enoch
Obeng Enoch
JSJianliang Shen
Jianliang Shen
Pathogenic bacteria infection is a serious threat to human public health due to the high morbidity and mortality rates. Nano delivery system for delivering antibiotics provides an alternative option to improve the efficiency compared to conventional therapeutic agents. In addition to the drug loading capacity of nanocarriers, which is typically around 10%, further lowers the drug dose that pathological bacteria are exposed to. Moreover, nanocarriers that are not eliminated from the body may cause side effects. These limitations have motivated the development of self‐delivery systems that are formed by the self‐assembly of different therapeutic agents. In this study, a vehicle‐free antimicrobial polymer polyhexamethylene biguanide (PHMB, with bactericidal and anti‐biofilm functions) hybrid gold nanoparticle (Au NPs, with photothermal therapy (PTT)) platform (PHMB@Au NPs) is developed. This platform exhibits an excellent synergistic effect to enhance the photothermal bactericidal effect for Staphylococcus aureus under near‐infrared irradiation. Furthermore, the results showed that PHMB@Au NPs inhibit the formation of biofilms, quickly remove bacteria to promote wound healing through PTT in infection model in vivo, and even mediate the transition of macrophages from M1 to M2 type, and accelerate tissue angiogenesis. PHMB@Au NPs will have promising value as highly effective antimicrobial agents for patient management.